歐洲藥品局（EMA）于2017年10月發(fā)布了"歐洲聯(lián)盟草藥專論和草藥目錄審核和修訂程序"。該文件詳細(xì)描述了歐洲聯(lián)盟草藥專論和草藥目錄的修訂過(guò)程，包括審核新數(shù)據(jù)、判斷新數(shù)據(jù)與需要修訂專論的相關(guān)性和修訂。詳細(xì)介紹該文件的主要內(nèi)容，期望對(duì)我國(guó)中草藥的醫(yī)學(xué)評(píng)價(jià)有所啟迪。

The EMA issued the "Procedure for the review and revision of European Union herbal monographs and European Union list entries" in October 2017. The document detailed the revision process of European Union herbal monographs and European Union list entries, including reviewing new data, judging the relevance of new data and the need of revision of monograph and revising. This paper introduced the contents of this document in detail, which is expected to enlighten the medical evaluation of Chinese herbal medicines.